Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Hot Topics
  • Published:

Fueling the future: brain bioenergetics as a driver of neurodevelopment and mental health trajectories

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Fig. 1: Brain bioenergetics as a central regulator of neurodevelopment and psychiatric vulnerability.

References

  1. Valenti D, Vacca RA. Brain mitochondrial bioenergetics in genetic neurodevelopmental disorders: focus on down, rett and fragile X syndromes. Int J Mol Sci. 2023;24:12488. https://doi.org/10.3390/ijms241512488.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  2. Rajan A, Fame RM. Brain development and bioenergetic changes. Neurobiol Dis. 2024;199:106550. https://doi.org/10.1016/j.nbd.2024.106550.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  3. Khaliulin I, Hamoudi W, Amal H. The multifaceted role of mitochondria in autism spectrum disorder. Mol Psychiatry. 2025;30:629–50. https://doi.org/10.1038/s41380-024-02725-z.

    Article  CAS  PubMed  Google Scholar 

  4. Omori NE, Malys MK, Woo G, Mansor L. Exogenous ketone bodies and the ketogenic diet as a treatment option for neurodevelopmental disorders. Front Nutr. 2024;11:1485280. https://doi.org/10.3389/fnut.2024.1485280.

    Article  PubMed  PubMed Central  Google Scholar 

  5. Bradlow RCJ, Berk M, Kalivas PW, Back SE, Kanaan RA. The potential of N-acetyl-L-cysteine (NAC) in the treatment of psychiatric disorders. CNS Drugs. 2022;36:451–82. https://doi.org/10.1007/s40263-022-00907-3.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  6. Gerasimenko M, Cherepanov SM, Furuhara K, Lopatina O, Salmina AB, Shabalova AA, et al. Nicotinamide riboside supplementation corrects deficits in oxytocin, sociability and anxiety of CD157 mutants in a mouse model of autism spectrum disorder. Sci Rep. 2020;10:10035. https://doi.org/10.1038/s41598-019-57236-7.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Contributions

SJT conceived the manuscript concept and structure. SJT conducted the literature review and wrote the initial draft of the manuscript. KRC contributed to the refinement of the scientific content and provided critical feedback on structure, clarity, and interpretation. Both authors were involved in iterative revisions and approved the final manuscript. SJT led the integration of emerging literature and coordinated the alignment of the manuscript with the journal’s thematic focus. All authors contributed substantially to the intellectual content.

Corresponding author

Correspondence to Susannah J. Tye.

Ethics declarations

Competing interests

The authors declare no competing interests.

Additional information

Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Tye, S.J., Cullen, K.R. Fueling the future: brain bioenergetics as a driver of neurodevelopment and mental health trajectories. Neuropsychopharmacol. (2025). https://doi.org/10.1038/s41386-025-02230-z

Download citation

  • Published:

  • DOI: https://doi.org/10.1038/s41386-025-02230-z

Search

Quick links